TiAb UROLOGICAL GEL (Urology)

TiAb UROLOGICAL GEL (Urology)
Product Description

TiAb Urological Gel is a Medical Device indicated as adjuvant in the natural healing process of not complicated post-surgical lesions and as adjuvant in the treatment of viral, fungal and bacterial infections. It is a cream-gel made from TiAb (a patented complex of titanium dioxide with covalently linked monovalent silver ions), sodium hyaluronate and aloe vera. TiAb Urological Gel creates a protective barrier on the surgical lesion in order to isolate and protect tissues against pathogenic noxae. Thanks to its properties and to the ancillary action of its components, it exerts a hydrating and soothing action as well, it isolates the point of application of the external microbial aggressions (barrier effect) thanks also to the presence of dimethicone. Presentation: multidose gel 25-50ml containing TiAB, dimethicone, aloe vera and sodium hyaluronateCE Mark expiry date: 31/12/2024 under EU Directive (MDR in progress)

Read more Show less

NTC S.r.l.

  • IT
  • 2015
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (innovator finished products)
View company profile
Categories
more categories Show less
Specifications
  • Supplied from
    Italy
More specifications Fewer specifications

NTC S.r.l.

  • IT
  • 2015
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (innovator finished products)
View company profile

More Products from NTC S.r.l. (29)

show all 29 other products

NTC S.r.l. resources (9)

  • NTC expands into pediatric allergology

    News NTC expands into pediatric allergology

    NTC Srl, R&D driven pharmaceutical companywith headquarters in Italy focused in ophthalmology, announces results from apolycentric study on Lertal®, a multicomponent nutraceutical, as add-on treatmentin children with allergic rhinoconjunctivitis (AR).
    3 Sep 2019
  • Therapeutical areas - brochure

    Brochure Therapeutical areas - brochure

    Advanced scientific research and technology drive our efforts to innovate care practices.
    Our range of products builds from our historical vocation for innovation aimed at improving the experience of patients and healthcare practices.
    An innovation aimed at discovering specific therapeutic gestures: simple and intuitive,  sustainable, and technically advanced for empowering the patient.
    Our research aims to put pioneering new products within the reach of everyone and to optimize the
    performance of our products by analyzing the daily needs and habits of people undergoing treatment.
    We research, develop and produce innovative drugs, medical devices and food supplements.
    We market our products worldwide through licensing, distribution, marketing, and commercial deals with partner companies.
    Our core therapeutic areas are: Ophthalmology, Gastro-Metabolism, Pediatrics and Gynacology.

  • NTC news: Post-cataract surgery

    News NTC news: Post-cataract surgery

    Last June, in Milan, NTC held a very important Investigators’ Meeting of two pivotal registration studies for a novel drug indicated in post cataract surgery: over 50 centers were involved in such large clinical effort and attended the event.
    23 Jul 2019
  • NTC: Novelty

    Video NTC: Novelty

    NTC: Novelty
    2023-10-05
  • NTC: Technology

    Video NTC: Technology

    NTC Technology
    2023-10-05
  • NTC: Care

    Video NTC: Care

    NTC Care
    2023-10-05
  • Value Report 2022

    Brochure Value Report 2022

    We focus on Novelty, Technology and we Care of our partners, customers, patients and of our people.

    The following information is intended for healthcare professionals only.

  • Value Report 2021

    Brochure Value Report 2021

    In NTC, we research, develop and produce innovative drugs, medical devices and food supplements.
    We market our products worldwide through licensing, distribution, marketing, and
    commercial deals with partner companies.
    In 2020, NTC consolidated its leadership in its fields of specialization by expanding its
    partnership network into Europe and Asia.
    Read more!
  • VALUE REPORT 2020

    Brochure VALUE REPORT 2020

    As a global player in the area of B2B, NTC is present in almost 100 countries and workwith around 200 partner companies. In addition, it carries out direct commercial activities (B2C) in the field of Ophthalmology in Italy and Spain.Dedicated to creating sustainable value, NTC has integrated social and environmentalconsiderations into its business operations and into its dealings with stakeholders. As partof its commitment to Corporate Social Responsibility, NTC has embedded internationalguidelines and procedures in its processes and practices.